Clinical and Medical Engineering Live
ISSN: 2997-612X | DOI: 10.64030/2997-612X
Durante, Caryl, Limos Honey Jane and Liwanag Friend Philemon
Identifying cutaneous lesions among persons living with human immunodeficiency virus (HIV) can present as a diagnostic challenge. Bacillary angiomatosis (BA) is a rare disease characterized by neovascular proliferation of the skin, presenting as tumor-like masses[1]. Since the advent antiretroviral therapy (ART), bacillary angiomatosis have been rare amongst patients with HIV [1]. We present a case of a 37-year-old male, coming in with 2 year history of generalized multiple violaceous plaques, with exophytic nodules on the lower extremities, that bleed easily when disturbed. An immunocompromised condition was considered after admission for pneumonia and persistence of cutaneous lesions. After testing positive for HIV, he was started on Lamivudine/Tenofovir/Efavirenz (LTE) with good compliance. Worsening of his lesions were observed 1 month after ART, prompting referral to our HIV and AIDS Core Team (HACT) Clinic. He was initially treated as plaque psoriasis with seborrheic dermatitis, but biopsy revealed bacillary angiomatosis. Significant improvement of cutaneous lesions were observed 1 month post oral erythromycin therapy.